121 – 130 of 174
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Urinary osteocalcin and other markers of bone metabolism: the effect of risedronate therapy
- Contribution to journal › Article
-
Mark
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis
- Contribution to journal › Article
-
Mark
3-year follow-up of 215 fracture patients from a prospective and consecutive osteoporosis screening program. Fracture patients care!
- Contribution to journal › Article
-
Mark
Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis : the GENOMOS study
- Contribution to journal › Article
- 2007
-
Mark
Residual lifetime risk of fractures in women and men
- Contribution to journal › Article
-
Mark
Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis
- Contribution to journal › Article
-
Mark
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial
- Contribution to journal › Article
- 2006
-
Mark
The association between common vitamin D receptor gene variations and osteoporosis : a participant-level meta-analysis
- Contribution to journal › Article
-
Mark
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis
- Contribution to journal › Article
-
Mark
Costs and quality of life associated with osteoporosis-related fractures in Sweden
- Contribution to journal › Article